ge healthcare (nyse: ge) provides transformational medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world. while we encourage and welcome comments to our linkedin page, these posts from members of the public do not necessarily represent ge healthcare views, and we do not confirm their accuracy or endorse them. ge healthcare is part of highly regulated medical device and pharmaceutical industry. posts and conversations may be removed as a result, but may be forwarded to other people within ge healthcare for follow-up as appropriate. as part of our commitment to you and to the rest of the linkedin members, we will do our best to ensure that the content on the page remains positive. however, since we cannot monitor every post or conversation feed, we realize that the occasional objectionable posts will pop up just from time to time. therefore, the company reserves the right to remove any postings at i
Company profile
Ticker
GEHC
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
GE Healthcare Holding LLC
SEC CIK
Corporate docs
Subsidiaries
Beijing GE Hualun Medical Equipment Company Limited • BK Medical ApS • BK Medical Australia Pty Ltd. • BK Medical Austria GmbH • BK Medical Benelux NV • BK Medical France SAS • BK Medical Holding Company, Inc. • BK Medical Italia S.r.l. • bk medical Medizinische Systeme GmbH • BK Medical Schweiz GmbH ...
IRS number
882515116
GEHC stock data
Latest filings (excl ownership)
8-K
Prices Upsized Secondary Offering of 14,000,000 Shares
14 Mar 24
424B3
Prospectus supplement
14 Mar 24
FWP
Free writing prospectus
12 Mar 24
8-K
GE HealthCare Technologies Inc. Commences Secondary Offering of 13,000,000 Shares
16 Feb 24
424B4
Prospectus supplement with pricing info
16 Feb 24
424B3
Prospectus supplement
15 Feb 24
S-3ASR
Automatic shelf registration
15 Feb 24
S-3ASR
Automatic shelf registration
9 Feb 24
8-K/A
GE HealthCare Reports Fourth Quarter and Full Year 2023 Financial Results
6 Feb 24
8-K/A
GE HealthCare Reports Fourth Quarter and Full Year 2023 Financial Results
6 Feb 24
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | |
---|---|---|
Revenue | ||
Cost of revenue | ||
Operating income | ||
Operating margin | ||
Net income | ||
Net profit margin | ||
Cash on hand | ||
Change in cash | ||
Diluted EPS |
Institutional ownership, Q4 2023
67.1% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 937 |
Opened positions | 116 |
Closed positions | 241 |
Increased positions | 328 |
Reduced positions | 335 |
13F shares | Current |
---|---|
Total value | 22.26 tn |
Total shares | 305.43 mm |
Total puts | 79.51 k |
Total calls | 60.24 k |
Total put/call ratio | 1.3 |
Largest owners | Shares | Value |
---|---|---|
GE General Electric | 61.58 mm | $4.76 tn |
Capital Research Global Investors | 51.34 mm | $3.97 tn |
Vanguard | 44.41 mm | $3.43 tn |
STT State Street | 18.58 mm | $1.44 tn |
Dodge & Cox | 16.98 mm | $1.31 tn |
T. Rowe Price | 12.09 mm | $935.10 mm |
Hotchkis & Wiley Capital Management | 5.51 mm | $426.19 bn |
IVZ Invesco | 5.39 mm | $416.86 bn |
MS Morgan Stanley | 5.01 mm | $387.54 bn |
Newport Trust | 4.36 mm | $337.15 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Mar 24 | General Electric | Common stock, par value $0.01 per share | Other | Dispose J | No | No | 0 | 14,000,000 | 0.00 | 32,631,302 |
1 Mar 24 | Thomas J. Westrick | Common Stock, par value $0.01 per share | Grant | Acquire A | No | No | 0 | 2,965 | 0.00 | 20,259 |
1 Mar 24 | Thomas J. Westrick | Common Stock, par value $0.01 per share | Payment of exercise | Dispose F | No | No | 91.28 | 2,121 | 193.60 k | 17,294 |
1 Mar 24 | Thomas J. Westrick | Common Stock, par value $0.01 per share | Payment of exercise | Dispose F | No | No | 91.28 | 1,169 | 106.71 k | 19,415 |
1 Mar 24 | Thomas J. Westrick | Common Stock, par value $0.01 per share | Payment of exercise | Dispose F | No | No | 91.28 | 1,285 | 117.29 k | 20,584 |
1 Mar 24 | Thomas J. Westrick | Common Stock, par value $0.01 per share | Payment of exercise | Dispose F | No | No | 91.28 | 1,195 | 109.08 k | 21,869 |
1 Mar 24 | Thomas J. Westrick | Employee Stock Option Common Stock, par value $0.01 per share | Grant | Acquire A | No | No | 92.72 | 8,435 | 782.09 k | 8,435 |
1 Mar 24 | Kenneth R. Stacherski | Common Stock, par value $0.01 per share | Grant | Acquire A | No | No | 0 | 4,718 | 0.00 | 57,549 |
1 Mar 24 | Kenneth R. Stacherski | Employee Stock Option Common Stock, par value $0.01 per share | Grant | Acquire A | No | No | 92.72 | 13,420 | 1.24 mm | 13,420 |
1 Mar 24 | Saccaro James | Common Stock, par value $0.01 per share | Grant | Acquire A | No | No | 0 | 10,245 | 0.00 | 71,938 |
News
GE HealthCare Unveils AI-Enabled Urology Software Feature Prostate Volume Assist
27 Mar 24
Wipro GE Healthcare Sets Sight on India's Healthcare Growth with $960M Investment
26 Mar 24
GE HealthCare Announces FDA Clearance Of nCommand Lite By IONIC Health
25 Mar 24
Jim Cramer Reveals Nvidia's Non-Tech Partners That Can Be Potential Market Winner: 'Best Opportunities'
19 Mar 24
GE HealthCare And Hartford HealthCare Renew 7-Year Collaboration To Advance Patient Care and Access in Connecticut
14 Mar 24
Press releases
GE HealthCare Announces the FDA Clearance of nCommand Lite by IONIC Health
25 Mar 24
GE HealthCare Announces Cash Dividend for First Quarter of 2024
22 Mar 24
GE HealthCare to Feature Latest Technologies in Interventional Radiology Focused on Precision Care at SIR 2024
22 Mar 24
GE HealthCare Accelerates AI Innovation with Healthcare-Specific Foundation Models Powered by NVIDIA
18 Mar 24
GE HealthCare and Hartford HealthCare Renew and Evolve 7-Year Collaboration to Advance Patient Care and Access in Connecticut
14 Mar 24